The Board oversees TTMI operations and advises on strategy, approves internal policy, and monitors the research performance of the Institution. Such governance is extremely valuable, and the Institute is fortunate to benefit from the expertise of an esteemed voluntary panel, who display immense drive and willingness to advance and build future capability and capacity. Members of the TTMI Board are as follows:
Prof. John Hegarty:
John Hegarty is a former Provost/President (2001-11) and now Fellow Emeritus of Trinity College Dublin. He previously served as Dean of Research and Head of the Physics Department and was Professor of Laser Physics from 1986. He was a researcher in the US from 1977-86 in the University of Wisconsin-Madison and Bell Laboratories in New Jersey, respectively, in the area of photonics. He holds a PhD in physics from NUIG and a BSc and HDipEd from Maynooth. Since 2012 he has been a Director with Innovation Advisory Partners. He is a member of the Irish Times Trust CLG, a member and former Chair of the Irish Fulbright Commission, and a Member of the Hugh Lane Gallery Board. He is also a Member of the Royal Irish Academy and a Fellow of the Institute of Physics. He was awarded honorary doctorates by UCD, QUB and UU.
Mr. Lorcan Birthistle:
Lorcan Birthistle is Chief Executive of St. James’s Hospital, Ireland’s largest acute teaching hospital. Lorcan was previously Chief Executive of Our Lady’s Children’s Hospital Crumlin and St. Luke’s Hospital in Rathgar. He is a graduate of the National College of Industrial Relations and Trinity College Dublin. Lorcan is presently Vice President of the Health Management Institute of Ireland and is a member of the Scientific Committee of the European Association of Hospital Managers. He is also a member of the governing Board of the Wellcome Trust / Health Research Board Clinical Research Facility at St. James’s Hospital.
Mr. Oliver Tattan
Oliver Tattan is an entrepreneur and investor in the insurance, healthcare and IT sectors. He is a founder of health insurer GloHealth, investment manager ‘Insurance Regulatory Capital’, consumer network OneBigSwitch, health insurer Vivas (now Irish Life Health) and biometric identity manager Daon. Oliver is currently Chairman of Fadata, a software provider to insurers; also of Brookson, an accountancy platform; and ARCH, a research centre in connected health. He is also an INED with AGF International and of CPL Resources plc.
Prof. Mary McCarron:
Prof. Linda Doyle
Linda Doyle is Professor of Engineering & The Arts in Trinity College Dublin. Prior to taking on the role of Dean of Research at Trinity College Dublin, she was the Director of the CONNECT SFI Research, a national research centre focused on future networks and communications. Her expertise is in the fields of wireless communications, cognitive radio, reconfigurable networks, spectrum management and creative arts practices. Prof. Doyle has a reputation as an advocate for change in spectrum management practices and has played a role in spectrum policy at the national and international level. Currently she is a member of the National Broadband Steering Committee in Ireland, and is a member of the Ofcom Spectrum Advisory Board in the UK. Linda was one of the founders of the Orthogonal Methods Group, a research platform that works in critical and creative tension with technology with the purpose of generating knowledges, insights and alternative research orientations across disciplines that are sometimes perceived to be mutually exclusive. She is a Fellow of Trinity College Dublin. She is the Chair of the Douglas Hyde Gallery.
Prof. Michael Gill:
Professor Michael Gill (MD, MRCPsych FTCD) is Professor of Psychiatry and Head of School of Medicine at Trinity College Dublin. Between 2012 and 2017, he was Director and Principal Investigator of the Wellcome/HRB Clinical Research Facility at St. James’ Hospital that opened in 2013 . He is a Board Member of HRB Clinical Research Coordination Ireland (HRB CRCI) and a former Director of the HRB CRCI. He is the Director, and a grant holder, of the Wellcome-HRB Irish Clinical Academic Training (ICAT) programme, an all Island consortium of six Universities that appoints and trains clinician scientists across all specialities. He was appointed as Head of the School of Medicine at Trinity College Dublin in September 2017. His research interests have focused on the genomics of neuropsychiatric disorders
Prof. Sylvia Draper:
Prof. Sylvia Draper graduated in Chemistry from the University of Exeter (1:1) in 1988 and received her Ph.D. from the University of Cambridge in 1992, working with Catherine Housecroft. Her research into optoelectronic materials embraces the syntheses of functional molecules from nanographenes to phosphors and with applications that include photonics, bio-imaging and Photodynamic Therapy. She is a recipient of both a Provost Teaching Award and a National Award for the Integration of Research Teaching and Learning (NAIRTL, excellence award) (2008). She was Head of Discipline in Inorganic and Synthetic Materials from 2003-11 and Head of School of Chemistry from 2013-17. In 2017 she was appointed Fellow of the Royal Society of Chemistry (F.R.S.C.). She is the Irish Representative on the R.S.C. Heads of Chemistry UK standing committee and a fellows’ representative on the Board of Trinity College Dublin.
Prof. Eleanor Molloy:
Eleanor Molloy is the Professor and Chair of Paediatrics, Trinity College Dublin, and a Consultant Neonatologist & Paediatrician at the Coombe Women and Infant’s University Hospital, the National Children’s Hospital, Tallaght, and Our Lady’s Children’s Hospital, Crumlin. From 2009 to 2014 she was Associate Professor of Paediatrics at the Royal College of Surgeons, from 2013 to 2014 she was Director of Paediatrics at the National Maternity Hospital, and from 2005 to 2014 she was a Senior Clinical Lecturer in Paediatrics, University College Dublin. From 2003 to 2005 she was a Neonatology Fellow at the Rainbow Babies & Children’s Hospital, Cleveland, USA.
Prof John Gilmer:
John Gilmer is Professor in Pharmaceutical Chemistry and Director of Postgraduate Teaching and Learning at the School of Pharmacy and Pharmaceutical Sciences, TCD. John holds a PhD in molecular recognition chemistry from TCD (1995). He held postdoc and visiting researcher positions in commercial pharmaceutical R&D at TCD and QUB from 1995 to 1998 when he was appointed lecturer in the School of Pharmacy at TCD. John has extensive experience as consultant on pharma manufacturing and legal issues. He contributes to the TCD pharmacy degree and to a range of postgraduate courses related to pharmaceutical manufacturing and development, including MSc programs in Pharmaceutical Sciences and Pharmaceutical Manufacturing Technology (QP). John has an active research group in diverse fields of drug discovery and delivery. He is a co-founder and Director of Research in Solvotrin Therapeutics, a pharmaceutical R&D company which won the 2010 EI award for innovation in the Life Sciences. Solvotrin has launched one product in Ireland and UK (2016-) and has several others in late stage development.
Prof. Aiden Corvin:
Aiden Corvin is Professor in Psychiatry at Trinity College Dublin and a Consultant Psychiatrist at St James’s Hospital, Dublin. He leads the TCD Psychosis Research Group and is interested in understanding the genetic basis of human disease. His work has been funded by agencies including Science Foundation Ireland (SFI), the Wellcome Trust and the US National Institute of Health (NIH). He is a lead-PI with the international Psychiatric Genomics Consortium (PGC). He has published more than 240 peer-reviewed articles (receiving more than 17,000 citations) and authored 8 book chapters. His H-Index is 55 and he is one of 12 Irish scientists on the current Thompson Reuters World’s Most Influential Minds List.
Prof. Orla Sheils
Orla Sheils has a PhD in Molecular Pathology from Trinity College Dublin and a MA in Medical Law and Ethics from Kings College London. The underlying theme of her research is to understand the causes and molecular basis of the development of disease, with particular reference to cancer, and to apply this knowledge to improving disease prevention, detection, diagnosis, and treatment. She has a particular interest in developing novel molecular diagnostics. Translational research is the common theme throughout Prof Sheils’ research, linking identification of disease processes with targets for early disease detection or classification. She works closely with industry bringing novel technologies and applications to the translational research setting.